Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xuefengdan Dripping Pills
- Development stage
- Unknown
- Lead developer
- Tasly Pharmaceutical
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Xuefengdan Dripping Pills is a traditional Chinese medicine (TCM) therapeutic candidate developed by Shanghai Leyu Biotechnology for the treatment of stable exertional angina pectoris and coronary heart disease. It is specifically formulated for patients diagnosed with 'Heart Blood Stasis Syndrome' (心血瘀阻证) according to TCM principles. The drug is delivered as dripping pills, a dosage form designed to enhance bioavailability and provide a rapid onset of action. Its primary therapeutic mechanism involves promoting blood circulation and resolving blood stasis, which helps to alleviate myocardial ischemia and reduce the frequency and severity of angina attacks. The active constituents are likely derived from botanical sources, such as *Acer* species, which have traditional applications in cardiovascular health.
- Brand names
- Xuefengdan
- Other names
- 血枫丹滴丸
02
Targets
BCL-2 (BCL-2 family)Stimulator of interferon genes protein (STING)-TANK-binding kinase 1 (TBK1) complexVEGFA (Vascular endothelial growth factor A)SCN5A (Sodium channel protein type 5 subunit alpha)
Beyond the preview
Go deeper on Xuefengdan Dripping Pills.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Xuefengdan Dripping Pills.